[Table/Fig-3]:
Antifungal susceptibility testing pattern of Candida species - 33 isolates
| Species | Total No. 33 | Fluconazole | Voriconazole | Flucytosine | Amphotericin B | ||||||||
| S (%) | I | R | S (%) | I | R | S (%) | I | R | S (%) | I | R | ||
| C. albicans | 10 | 8(80) | 1 | 1 | 8(80) | 1 | 1 | 9(90) | 1 | - | 10(100) | - | - |
| C. tropicalis | 15 | 10(66.6) | 2 | 3 | 11(73.33) | 1 | 3 | 12(80) | 2 | 1 | 13(86.6) | 2 | - |
| C. krusei | 5 | 2(40) | - | 3 | 3(60) | - | 2 | 4(80) | - | 1 | 4(80) | 1 | - |
| C. glabrata | 3 | 2(66.6) | - | 1 | 2(66.6) | 1 | - | 2(66.6) | - | 1 | 3(100) | - | - |
| Overall % sensitivity to each antifungal drugs | 66.66% | 72.72% | 82% | 91% | |||||||||